|
Volumn 456, Issue , 1998, Pages 269-286
|
Bacterial two-component signalling as a therapeutic target in drug design: Inhibition of NRII by the diphenolic methanes (bisphenols)
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPHENOLIC METHANE DERIVATIVE;
PD 163892;
PD 164592;
PHENOL DERIVATIVE;
PROTEIN HISTIDINE KINASE;
PROTEIN KINASE INHIBITOR;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
DRUG DESIGN;
DRUG SYNTHESIS;
DRUG TARGETING;
ENZYME INHIBITION;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
BACTERIA (MICROORGANISMS);
|
EID: 0032226543
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-1-4615-4897-3_14 Document Type: Review |
Times cited : (11)
|
References (42)
|